Condition (MeSH)
Fetofetal Transfusion
ClinicalTrials.gov lists 46 trials for Fetofetal Transfusion or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
46 of the 46 trials are tagged with Fetofetal Transfusion itself; the rest are tagged with a narrower condition beneath it.
When did Fetofetal Transfusion trials start? (19)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 5
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 5 |
| 2024 | 3 |
| 2022 | 5 |
| 2021 | 3 |
| 2019 | 4 |
| 2018 | 4 |
| 2017 | 3 |
| 2016 | 4 |
| 2015 | 2 |
Showing 10 of 19 earlier years.
No forecast is made for this condition: it averages 3.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Prediction, not a registry value: median of 36 months from start to primary completion across 6 trials still running at the 2026-10-09 snapshot; registered median of 19 months across 25 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Fetofetal Transfusion trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 1 |
| Phase 4 | 1 |
| Not applicable | 30 |
| Observational | 13 |
How many Fetofetal Transfusion trials are recruiting? (7)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 2 |
| Recruiting | 7 |
| Active, not recruiting | 3 |
| Completed | 19 |
| Terminated | 4 |
Showing 5 of 7 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Interventions as named in the registry (4)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Delayed Cord Clamping (DCC) | 4 |
| Standard Treatment | 1 |
| Progesterone 8% | 1 |
| Timing of administration of post partum Oxytocin | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Fetofetal Transfusion? (79)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
Showing 5 of 79 publications.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Twin to twin transfusion syndrome | 95431 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Twin to twin transfusion syndrome | 95431 | Exact | Orphadata Science knowledge files, Product 1 |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, and sub-conditions in mesh.